230
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Novel polycyclic pyrroloquinazoline alkaloids from Anisotes trisulcus and their biological activity

, , , , , , & show all
Pages 1159-1167 | Received 20 Jun 2019, Accepted 13 Nov 2019, Published online: 23 Dec 2019
 

Abstract

Two new polycyclic pyrroloquinazoline alkaloids with unprecedented skeleton, anisulcusines A (1) and B (2), along with four known compounds (36), were identified from the aerial parts of Anisotes trisulcus (Forssk.) Nees. To our knowledge, anisulcusines A and B are the first polycyclic pyrroloquinazoline alkaloids that possess a unique N-methyl-1,2-dihydro-1'H-spiro[benzo[d][1,3]oxazine moiety. The chemical structures of the new compounds were elucidated through extensive spectroscopic analyses and high-resolution mass spectroscopy. Anisulcusine B (2) exerted moderate cytotoxic effect on cultured human hepatoma (HuH7) cells, whereas compounds 1 and 35 exhibited mild cell proliferative or growth stimulatory activity.

    HIGHLIGHTS

  • Two new polycyclic pyrroloquinazoline alkaloids from Anisotes trisulcus.

  • Structures were elucidated on the basis of 1D- and 2D-NMR and HR-ESI-MS spectra.

  • Compound (2) exerted moderate cytotoxic effect against human hepatoma (HuH7) cells.

  • Compounds (1, 35) exhibited mild cell proliferative or growth stimulatory activity.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was funded by the deanship of scientific research at the Princess Nourah Bint Abdulrahman University through the Research Groups Program Grant (no. RGP-1440-0014).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.